Current view on novel vaccine technologies to combat human infectious diseases.

ABSTRACT: Inactivated and live attenuated vaccines have improved human life and significantly reduced morbidity and mortality of several human infectious diseases. However, these vaccines have faults, such as reactivity or suboptimal efficacy and expensive and time-consuming development and production. Additionally, despite the enormous efforts to develop vaccines against some infectious diseases, the traditional technologies have not been successful in achieving this. At the same time, the concerns about emerging and re-emerging diseases urge the need to develop technologies that can be rapidly applied to combat the new challenges. Within the last two decades, the research of vaccine technologies has taken several directions to achieve safe, efficient, and economic platforms or technologies for nov

SUBMITTER: Matic Z 

PROVIDER: S-EPMC8661323 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature